Navigation Links
Mesenchymal Stem Cells - Advances & Applications 2013
Date:11/21/2013

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/l9ff49/mesenchymal_stem) has announced the addition of the "Mesenchymal Stem Cells - Advances & Applications 2013" report to their offering.
     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Understand and profit from the mesenchymal stem cell (MSC) product market - the fastest growing area of stem cell research.

Updated to reflect the most current trends and including five year market projections, this report focuses on the advances in MSC research. In 125 pages you'll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis.

Revealing Unique Strategic Opportunities & Unknown Competitive Advantages

MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. The report advantageously positions companies that wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

Expanded and Updated Market Intelligence

This is an expanded and updated market intelligence report that includes:

- Updated Charts, Timelines, Metrics and Financials

- 5-Year Projection Data through 2016

- Expanded Competitive Environment Analysis

- Detailed Characterization of the Market, Emphasizing Statistical Trends

- Exploration of Recent Product Evolution and Projected Directions for Development

- Overview of Therapeutic Progress and Insight into Future Applications

- Detailed Evaluation of Profit Opportunities

- New Section on End-User Needs & Technical Preferences (Scientist Survey!)

Companies Mentioned:

- Abcam
- BD Biosciences
- Cell Applications
- Celprogen
- Cyagen Biosciences (China only)
- Genlantis
- Invitrogen
- LGC Standards/ATCC
- Lonza
- Millipore
- Miltenyi Biotec
- PAA - The Cell Culture Company
- PromoCell
- R&D Systems
- SA Biosciences
- ScienCell Research Laboratories
- STEMCELL Technologies Inc
- Thermo Scientific
- Trevigen, Inc.

For more information visit http://www.researchandmarkets.com/research/l9ff49/mesenchymal_stem

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Mesenchymal Stem Cells Have New Cell Culture Environment
2. Mesenchymal Stem Cells Mobilize Body’s Own Healing Cells According to New Research Published in STEM CELLS Translational Medicine
3. New method for producing precursor of neurons, bone and other important tissues from stem cells
4. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
5. Notre Dame researchers develop paint-on solar cells
6. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
7. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
8. In solar cells, tweaking the tiniest of parts yields big jump in efficiency
9. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
10. Scientists Discover How a Bacterial Pathogen Breaks Down Barriers to Enter and Infect Cells
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... Md. , June 23, 2016 A person ... from the crime scene to track the criminal down. ... the U.S. Food and Drug Administration (FDA) uses DNA evidence ... Sound far-fetched? It,s not. The FDA ... sequencing to support investigations of foodborne illnesses. Put as simply ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
Breaking Biology Technology:
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):